# Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

> **NCT00593866** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 50 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **RADIATION:** INTENSITY MODULATED RADIOTHERAPY
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00593866
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2012-05
- **Final completion:** 2014-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593866, "Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00593866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*